KeyBank National Association’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-5,903
Closed -$262K 965
2018
Q3
$262K Sell
5,903
-1,760
-23% -$80.8K ﹤0.01% 935
2018
Q2
$300K Buy
7,663
+3,787
+98% +$191K ﹤0.01% 876
2018
Q1
$280K Sell
3,876
-1,115
-22% -$81.9K ﹤0.01% 894
2017
Q4
$329K Hold
4,991
﹤0.01% 864
2017
Q3
$250K Sell
4,991
-1,863
-27% -$89.8K ﹤0.01% 967
2017
Q2
$317K Sell
6,854
-334
-5% -$12.3K ﹤0.01% 935
2017
Q1
$254K Sell
7,188
-5,503
-43% -$126K ﹤0.01% 1015
2016
Q4
$159K Buy
+12,691
New +$151K ﹤0.01% 1099
2016
Q2
Sell
-10,599
Closed -$179K 1107
2016
Q1
$179K Buy
+10,599
New +$170K ﹤0.01% 1046
2015
Q3
Sell
-3,691
Closed -$302K 1160
2015
Q2
$302K Buy
3,691
+415
+13% +$40.6K ﹤0.01% 1003
2015
Q1
$303K Buy
+3,276
New +$211K ﹤0.01% 1012
2014
Q1
Sell
-10,693
Closed -$147K 1271
2013
Q4
$147K Buy
+10,693
New +$156K ﹤0.01% 1230

Other funds holding ESPR